| RS1641704371 |
NMNAT1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1641706044 |
RERE
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without anomalies of the brain, eye |
| RS1641722871 |
ATAD3A
|
Health Risk |
Likely pathogenic |
Harel-Yoon syndrome, Harel-Yoon syndrome |
| RS1641789657 |
NMNAT1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS1641791811 |
NMNAT1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS1641792104 |
NMNAT1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS1641936336 |
NMNAT1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS1641937559 |
NMNAT1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS1641939338 |
NMNAT1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS1641939445 |
NMNAT1
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia, sensorineural hearing loss |
| RS1641966003 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated focal cortical dysplasia type II, Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome |
| RS1641966303 |
NMNAT1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS1641966566 |
NMNAT1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS1641967500 |
NMNAT1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS1641967823 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1641970512 |
NMNAT1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis |
| RS1641971124 |
NMNAT1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS1641973290 |
NMNAT1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS1642122631 |
TRIT1
|
Health Risk |
Likely pathogenic |
TRIT1-related disorder, TRIT1-related disorder |
| RS1642202172 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome, Isolated focal cortical dysplasia type II |
| RS1642221044 |
C1QA
|
Health Risk |
Likely pathogenic |
C1Q deficiency, C1Q deficiency |
| RS1642345798 |
NPHP4
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1642683882 |
NPHP4
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1642913016 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1642915400 |
MTOR
|
Health Risk |
Likely pathogenic |
CEBALID syndrome, CEBALID syndrome |
| RS1643006514 |
PEX10
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS1643015669 |
PEX10
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS1643024516 |
MTOR
|
Health Risk |
Likely pathogenic |
— |
| RS1643025235 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1643027426 |
PEX10
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS1643028060 |
PEX10
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS1643028584 |
PEX10
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 6A (Zellweger), Peroxisome biogenesis disorder 6A (Zellweger) |
| RS1643083325 |
PEX10
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS1643085902 |
PEX10
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS1643093232 |
PEX10
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS1643098054 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1643176372 |
PRDM16
|
Health Risk |
Pathogenic |
Left ventricular noncompaction 8, Left ventricular noncompaction 8 |
| RS1643227639 |
VPS13D
|
Health Risk |
Pathogenic |
— |
| RS1643275394 |
PEX10
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS1643312973 |
PUM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia 47, Global developmental delay |
| RS1643435901 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1643440876 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1643441134 |
SLC2A1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1643441873 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1643441930 |
SLC2A1
|
Health Risk |
Likely pathogenic |
SLC2A1-related disorder, SLC2A1-related disorder |
| RS1643442142 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1643443081 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1643443798 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1643457017 |
SLC2A1
|
Health Risk |
Pathogenic |
Encephalopathy due to GLUT1 deficiency, Childhood onset GLUT1 deficiency syndrome 2 |
| RS1643459989 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1643470035 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1643479461 |
SLC2A1
|
Health Risk |
Likely pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1643479604 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1643480228 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1643480570 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1643480923 |
SLC2A1
|
Health Risk |
Likely pathogenic |
Encephalopathy due to GLUT1 deficiency, Intellectual disability |
| RS1643481831 |
SLC2A1
|
Health Risk |
Pathogenic |
Childhood onset GLUT1 deficiency syndrome 2, Childhood onset GLUT1 deficiency syndrome 2 |
| RS1643481875 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1643481930 |
SLC2A1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1643484242 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1643484307 |
SLC2A1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1643484447 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1643486648 |
ADPRS
|
Health Risk |
Pathogenic |
— |
| RS1643642110 |
DVL1
|
Health Risk |
Likely pathogenic |
Autosomal dominant Robinow syndrome 1, Autosomal dominant Robinow syndrome 1 |
| RS1643645439 |
DVL1
|
Health Risk |
Pathogenic |
Autosomal dominant Robinow syndrome 2, Autosomal dominant Robinow syndrome 2 |
| RS1643653768 |
TARDBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 10, FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS |
| RS1643659556 |
TARDBP
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 10, Amyotrophic lateral sclerosis type 10 |
| RS1643666556 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1643667928 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1643668441 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1643677014 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1643682280 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1643683466 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1643683813 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1643715509 |
PRDM16
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1643807832 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1643855445 |
EIF2B3
|
Health Risk |
Likely pathogenic |
Vanishing white matter disease, Vanishing white matter disease |
| RS1643857128 |
DVL1
|
Health Risk |
Likely pathogenic |
Autosomal dominant Robinow syndrome 2, Autosomal dominant Robinow syndrome 2 |
| RS1643875847 |
NPHP4
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1643882944 |
NPHP4
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1643944047 |
ESPN
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 36, Autosomal recessive nonsyndromic hearing loss 36 |
| RS1643945526 |
ESPN
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 36, Autosomal recessive nonsyndromic hearing loss 36 |
| RS1643950236 |
COL9A2
|
Health Risk |
Pathogenic |
— |
| RS1643987343 |
COL9A2
|
Health Risk |
Pathogenic |
— |
| RS1644046939 |
COL9A2
|
Health Risk |
Likely pathogenic |
— |
| RS1644052943 |
COL9A2
|
Health Risk |
Pathogenic |
— |
| RS1644090272 |
MTOR
|
Health Risk |
Likely pathogenic |
CEBALID syndrome, CEBALID syndrome |
| RS1644090362 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome, CEBALID syndrome |
| RS1644092513 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Neural tube defects |
| RS1644094173 |
COL9A2
|
Health Risk |
Pathogenic |
— |
| RS1644101576 |
COL9A2
|
Health Risk |
Likely pathogenic |
— |
| RS1644101814 |
COL9A2
|
Health Risk |
Pathogenic |
— |
| RS1644131579 |
ESPN
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 36, Autosomal recessive nonsyndromic hearing loss 36 |
| RS1644169357 |
CEP104
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1644186925 |
MTHFR
|
Health Risk |
Pathogenic/Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS1644212098 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Neural tube defects |
| RS1644227005 |
MTHFR
|
Health Risk |
Pathogenic/Likely pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Neural tube defects |
| RS1644227125 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS1644227167 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS1644230120 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Neural tube defects |